Meaningful use will now include quality reporting under new MACRA guideline and deadlines are extended through 2020. Providers now have more time to attest. Only Praxis automates MU, helping you reach 100% with ease.
Disclaimer: Praxis does not purport to represent or be an agent of HHS. Please access the CMS Quality Payment Program (https://qpp.cms.gov) to review any official or changing information.
Certificate Number: 15.02.05.2766.INFO.01.02.1.220310
Certification Date: 2022-03-10
Certificate Updated: 2022-12-12
Issued to: Infor*Med Medical Information Systems Inc.
5800 S Eastern Ave Suite 500, Commerce, CA 90040
Product: Praxis EMR Version 9
Standard(s): 45 CFR 170 Subpart C
Additional software required to satisfy select certification criteria: EMR Direct
EMR Direct's ONC-ACB Certification ID: 15.04.04.1397.Inte.17.00.0.161117
This Health IT Module is 2015 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.
ONC CERTIFIED HIT® is a registered trademark of HHS.
Stage 2 Meaningful Use has been extended through 2020, and providers now have more time to attest. Only Praxis automates MU, helping you reach 100% with ease.Read More
Praxis pledges to take you through Meaningful Use Stage 2 and beyond!
See our step-by-step guide to preparing and attesting.
Praxis is ONC-ACB certified as a Health IT Module.
Now you can secure the EHR incentives that you deserve with no stress!
|CMS 50||Closing the Referral Loop: Receipt of Specialist Report||v4, v7|
|CMS 52||HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis||v7|
|CMS 62||HIV/AIDS: Medical Visit||v4|
|CMS 65||Hypertension: Improvement in Blood Pressure||v5, v8|
|CMS 66||Functional Status Assessment for Total Knee Replacement||v7|
|CMS 74||Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists||v5, v8|
|CMS 75||Children Who Have Dental Decay or Cavities||v4, v7|
|CMS 77||HIV/AIDS: RNA Control for Patients with HIV||v4|
|CMS 82||Maternal Depression Screening||v3, v6|
|CMS 90||Functional Status Assessments for Congestive Heart Failure||v5, v8|
|CMS 117||Childhood Immunization Status||v7|
|CMS 122||Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)||v7|
|CMS 123||Diabetes: Foot Exam||v7|
|CMS 124||Cervical Cancer Screening||v4, v7|
|CMS 125||Breast Cancer Screening||v4, v7|
|CMS 126||Use of Appropriate Medications for Asthma||v4|
|CMS 127||Pneumonia Vaccination Status for Older Adults||v4, v7|
|CMS 129||Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients||v8|
|CMS 130||Colorectal Cancer Screening||v7|
|CMS 131||Diabetes: Eye Exam||v7|
|CMS 132||Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures||v7|
|CMS 134||Diabetes: Medical Attention for Nephropathy||v7|
|CMS 138||Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention||v7|
|CMS 139||Falls: Screening for Future Fall Risk||v7|
|CMS 145||Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)||v7|
|CMS 146||Appropriate Testing for Children with Pharyngitis||v7|
|CMS 148||Hemoglobin A1c Test for Pediatric Patients||v4|
|CMS 153||Chlamydia Screening for Women||v7|
|CMS 161||Adult Major Depressive Disorder (MDD): Suicide Risk Assessm.||v4, v7|
|CMS 163||Diabetes: Low Density Lipoprotein (LDL) Management||v4|
|CMS 165||Controlling High Blood Pressure||v4, v7|
|CMS 166||Use of Imaging Studies for Low Back Pain||v5|